Deutsche Bank’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $780K | Sell |
48,771
-362,738
| -88% | -$5.8M | ﹤0.01% | 2224 |
|
|
2025
Q1 | $7.03M | Buy |
411,509
+245,037
| +147% | +$4.19M | ﹤0.01% | 1116 |
|
|
2024
Q4 | $4.12M | Buy |
166,472
+16,903
| +11% | +$419K | ﹤0.01% | 1420 |
|
|
2024
Q3 | $4.26M | Buy |
149,569
+6,595
| +5% | +$188K | ﹤0.01% | 1327 |
|
|
2024
Q2 | $3.77M | Sell |
142,974
-2,451
| -2% | -$64.7K | ﹤0.01% | 1333 |
|
|
2024
Q1 | $4.7M | Buy |
145,425
+1,032
| +0.7% | +$33.3K | ﹤0.01% | 1278 |
|
|
2023
Q4 | $6.08M | Buy |
144,393
+109,400
| +313% | +$4.61M | ﹤0.01% | 1164 |
|
|
2023
Q3 | $1.34M | Sell |
34,993
-107,689
| -75% | -$4.13M | ﹤0.01% | 1542 |
|
|
2023
Q2 | $2.71M | Buy |
142,682
+102,461
| +255% | +$1.94M | ﹤0.01% | 1483 |
|
|
2023
Q1 | $624K | Buy |
40,221
+8,253
| +26% | +$128K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $567K | Buy |
31,968
+5,381
| +20% | +$95.5K | ﹤0.01% | 2373 |
|
|
2022
Q3 | $148K | Buy |
26,587
+7,257
| +38% | +$40.4K | ﹤0.01% | 3107 |
|
|
2022
Q2 | $75K | Sell |
19,330
-4,278
| -18% | -$16.6K | ﹤0.01% | 3601 |
|
|
2022
Q1 | $130K | Sell |
23,608
-123,029
| -84% | -$677K | ﹤0.01% | 3448 |
|
|
2021
Q4 | $1.25M | Buy |
146,637
+1,548
| +1% | +$13.2K | ﹤0.01% | 2289 |
|
|
2021
Q3 | $1.26M | Sell |
145,089
-39,368
| -21% | -$342K | ﹤0.01% | 2455 |
|
|
2021
Q2 | $1.95M | Buy |
184,457
+24,511
| +15% | +$259K | ﹤0.01% | 2242 |
|
|
2021
Q1 | $2.57M | Buy |
159,946
+128,765
| +413% | +$2.07M | ﹤0.01% | 1975 |
|
|
2020
Q4 | $1.44M | Buy |
31,181
+10,105
| +48% | +$467K | ﹤0.01% | 2166 |
|
|
2020
Q3 | $742K | Sell |
21,076
-97,021
| -82% | -$3.42M | ﹤0.01% | 2374 |
|
|
2020
Q2 | $2.88M | Buy |
+118,097
| New | +$2.88M | ﹤0.01% | 1579 |
|